A multistate antitrust investigation on generic drug pricing has expanded further. It now includes suits against executives at generic makers.
In late October, Connecticut Attorney General George Jepsen and 45 other state attorneys general (AGs) asked United States District Court Eastern District Of Pennsylvania for permission to file a new complaint in the states’ pending lawsuit that increases the number of generic drug manufacturer defendants from 6 to 18 and the number of drugs at issue from 2 to 15.
Written by Christine Blank
